Navigation Links
AVMA Responds to Federal Order Limiting Use of Antibiotics In Food Animals

SCHAUMBURG, Ill., Jan. 6, 2012 /PRNewswire-USNewswire/ -- The American Veterinary Medical Association (AVMA) announced today that the FDA's order prohibiting certain uses of cephalosporins in food animals appears consistent with the current AVMA position on the limited prohibition on extra-label drug use, but warned against further restrictions not backed by science.

Cephalosporins, a class of antimicrobial drug used in livestock, poultry and other food-producing animals, are also commonly used in humans to treat pneumonia and a wide range of skin and soft tissue infections, urinary tract infections and inflammatory disease. The FDA said it is limiting the use of cephalosporins in animals to preserve the effectiveness of the drugs for treating disease in humans and reduce the risk of cephalosporin resistance in certain bacterial pathogens.

"The AVMA is pleased that the FDA reviewed and thoughtfully considered the many comments received from stakeholders, including veterinarians, while taking action to preserve the effectiveness of cephalosporin drugs for treating disease in humans," said Dr. Rene Carlson, AVMA president. "Veterinarians are committed to improving the health and welfare of people, animals and the environment, and we hope the FDA's order will allow veterinarians to have therapeutic options for food animals while also protecting public health."

The AVMA is evaluating the prohibition of cephalosporins for preventive uses and will submit a response to the FDA during the comment period. The AVMA has a strong position which underscores the importance of veterinary access to antimicrobials for preventive use to enhance food safety, public health and animal welfare.

"We are committed to the judicious use of antimicrobials in food animals," said Dr. Carlson. "While this measure appears to be consistent with our position, we will continue to review any further restrictions to make sure they are backed by science and don't place arbitrary and ultimately harmful limits on veterinarians' ability to treat animals and ensure a safe and healthy food supply."

For more information, contact Michael San Filippo, AVMA media relations assistant, at 847-285-6687 (office), 847-732-6194 (cell), or For more information about the AVMA, visit  

The AVMA, founded in 1863, is one of the oldest and largest veterinary medical organizations in the world, with more than 81,500 member veterinarians worldwide engaged in a wide variety of professional activities. For more information, visit

SOURCE American Veterinary Medical Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ampio Responds to Recent Publications by Anonymous Short Sellers
2. Nationwide Coalition Responds to Express Scripts CEO Statement: "I Cant Stop Certain Pharmacies From Going Out of Business"
3. China Medical Technologies Responds to the Allegations Raised by Glaucus Research Group
4. International Academy of Compounding Pharmacists (IACP) Responds to FDAs Appeal of the U.S. District Court Ruling on Pharmacy Compounding
5. Intellect Neurosciences Responds to Official Action by United States Patent and Trademark Office in Relation to its ANTISENILIN® Alzheimers Patent Application
6. NeuroSigma Responds to Substantial Interest Generated by NPR Story on Promising Epilepsy Clinical Trial
7. Cellestis Responds to World Health Organization Guidance on Use of Blood Tests for Active Tuberculosis
8. Takeda Responds to U.S. Food and Drug Administration Update to Safety Review of ACTOS (pioglitazone HCl)
9. Valeant Pharmaceuticals Responds to Cephalon Boards Letter
10. NCPA Responds to Consumer Groups Request for CVS Caremark Divestiture
11. Mangrove Partners Responds to Erroneous CPEX Assertions
Post Your Comments:
(Date:12/1/2015)... During the recent 2015 Transcatheter Cardiovascular ... CA , Medinol Ltd. continued to introduce ... a satellite symposium, "The BioNIR eDES: The Role ... a renowned physician panel discussed the key attributes ... Stent System and the Medinol eDES Coronary Stent ...
(Date:12/1/2015)... YORK , Dec. 1, 2015 Relmada Therapeutics, ... the treatment of chronic pain, announced today that the company ... will be held December 1-3 at the Luxe Sunset Boulevard ... Sergio Traversa , CEO of Relmada Therapeutics, will present on ... Eastern Time). . Please register at least ...
(Date:12/1/2015)... Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), a ... of therapies for cardiovascular conditions via the inhalation route, ... in Australia . InCarda is planning ... Australia in the first half of ... medical centers in Adelaide and ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... The workstation boundaries for ... IMAGE Information Systems launches MED-TAB™ -- the world’s first portable DICOM-calibrated medical image ... 29 to December 4, 2015. , MED-TAB is expected to change teleradiology ...
(Date:12/1/2015)... ... , ... The importance of volumetric breast density assessment for ... abstracts accepted for presentation here, at the 101st Annual Radiology Society of North ... of Volpara Solutions’ quantitative breast imaging software tools for providing breast imaging and ...
(Date:12/1/2015)... ... December 01, 2015 , ... For ... That is why Hollister Incorporated has launched the VaPro Plus Pocket™ touch free ... in the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice President North ...
(Date:12/1/2015)... ... December 01, 2015 , ... SAN FRANCISCO, Calif. (December 1, ... organization has awarded Education and Developmental Therapies (EDT), an Applied Behavior Analysis (ABA) ... exceptional special needs providers that excel in synthesizing the areas of clinical quality, ...
(Date:12/1/2015)... ... December 01, 2015 , ... McLean, ... been awarded a fixed price per sprint agile development contract to support the ... million over five years, provides software engineering, infrastructure, as well as operations and ...
Breaking Medicine News(10 mins):